To address these shortcomings, we introduce SymPcNSGA-Testing (Symbolic execution, Path clustering and NSGA-II Testing), a ...
In patients who had progressed on one prior ARPI, FG3246 plus enzalutamide yielded a median radiographic progression-free survival (rPFS) of 10.1 months and PSA50 response of 40%. Phase I Monotherapy ...
Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Q4 2025 earnings recap: record store openings, 2% comp and 40.5% margin targets, buyback plans, and 2026 guidance—read the highlights now.
How close are we to the sci-fi vision of autonomous humanoid robots? I visited 11 companies in five Chinese cities to find out ...
European Financials Conference 2026 March 18, 2026 5:00 AM EDTCompany ParticipantsCoimbatore Venkatakrishnan - Group CEO & ...
Medicine Bow Beta. Oppression leads to wealth? Grudge that a bouquet shot would be humiliating! Hot brine or dry curry leaves? Stimulus job count by doing bore well. A learner to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results